June 17 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER
News: KZA U.S. FDA Awards Orphan Drug Designation To Paxalisib For AT/RT, A Rare Form Of Childhood...
Add to My Watchlist
What is My Watchlist?